A retrospective, observational study comparing outcomes of asthma treatment with fixed combinations of inhaled corticosteroid and long-acting a2-agonist (ICS/LABA) in real-life practice

被引：0
|
作者：
Thomas, M. [1 ]
Von Ziegenweidt, J. [2 ]
Wiren, A. [3 ]
Stahl, E. [3 ]
Price, D. [1 ]
机构：
[1] Univ Aberdeen, Aberdeen, Scotland
[2] Resp Res Ltd, Aberdeen, Scotland
[3] AstraZeneca, Lund, Sweden
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)64912-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A240 / A241
页数：2
相关论文
共 50 条
  • [1] Asthma treatment in children and adolescents with fixed combination of inhaled corticosteroid (ICS)/long-acting beta 2 agonist (LABA). An update
    Gappa, Monika
    PNEUMOLOGE, 2021, 18 (05): : 320 - 325
  • [2] A retrospective study comparing treatment patterns, outcomes, and resource use between two fixed combinations of inhaled corticosteroids and long-acting b2-agonist (ics/laba) in asthmatic patients in germany
    Aballea, S.
    Cure, S.
    Vogelmeier, C.
    Wiren, A.
    VALUE IN HEALTH, 2007, 10 (06) : A402 - A403
  • [3] Assessing the Relationship between Combination Long-Acting Beta Agonist (LABA) and Inhaled Corticosteroid (ICS) Use and Serious Asthma Outcomes
    Wells, Karen E.
    Peterson, Edward L.
    Williams, L. Keoki
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S66 - S66
  • [4] Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
    Price, David
    Bousquet, Jean
    RESPIRATORY MEDICINE, 2012, 106 : S4 - S8
  • [5] Real-world effects of two inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
    Yatera, Kazuhiro
    Yamasaki, Kei
    Nishida, Chinatsu
    Noguchi, Shingo
    Oda, Keishi
    Akata, Kentarou
    Nagata, Shuya
    Kawanami, Yukiko
    Kawanami, Toshinori
    Ishimoto, Hiroshi
    Mukae, Hiroshi
    JOURNAL OF ASTHMA, 2014, 51 (07) : 762 - 768
  • [6] TREATMENT PERSISTENCE AND EXACERBATIONS IN PATIENTS WITH ASTHMA INITIATING TREATMENT WITH INHALED CORTICOSTEROIDS AND LONG-ACTING BETA-ADRENERGIC AGONISTS (ICS/LABA): REAL-LIFE STUDY
    Sicras-Mainar, A.
    Susana, T. L.
    Toni, F. S.
    Navarro-Artieda, R.
    VALUE IN HEALTH, 2019, 22 : S873 - S873
  • [7] Characteristics and treatment pathways of patients with COPD receiving an inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) in the UK
    Czira, Alexandrosz
    Banks, Victoria
    Requena, Gema
    Wood, Robert
    Tritton, Theo
    Ha, Eunmi
    Wild, Rosie
    Compton, Chris
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [8] Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
    Mueller, Veronika
    Galffy, Gabriella
    Eszes, Noemi
    Losonczy, Gyoergy
    Bizzi, Andrea
    Nicolini, Gabriele
    Chrystyn, Henry
    Tamasi, Lilla
    BMC PULMONARY MEDICINE, 2011, 11
  • [9] Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
    Veronika Müller
    Gabriella Gálffy
    Noemi Eszes
    György Losonczy
    Andrea Bizzi
    Gabriele Nicolini
    Henry Chrystyn
    Lilla Tamási
    BMC Pulmonary Medicine, 11
  • [10] Triple therapy of umeclidinium and inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) vs placebo plus ICS/LABA in GOLD D patients
    Kerwin, Edward
    Siler, Thomas
    Tombs, Lee
    Sousa, Ana R.
    Singletary, Karen
    Church, Alison
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345